The independent source for health policy research, polling, and news.
721-740 of 764 results
In a case with possible national repercussions, the stateās attorney general has sued over alleged price gouging, and other legal and legislative challenges are afoot. Sutter is pushing back hard, denying anticompetitive behavior.
A judge orders the county to fix problem that harmed low-income seniors and people with disabilities, including those with serious health conditions.
A lawsuit claims that a private company hired by the state public health department to manage enrollment in an AIDS drug assistance program for low-income patients inadvertently allowed unauthorized access to their medical status.
The lawsuit is a bold move against Northern Californiaās dominant hospital chain, whose prices have drawn complaints for years. It has disputed such allegations in the past.
In September, the Trump administration announced its plan to end the Deferred Action for Childhood Arrivals program, setting off an ongoing political and legal battle that could doom the dreams of immigrant doctors in training.
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it ā or at least salvage its own reputation.
Three participants in unauthorized herpes vaccine research file a lawsuit against scientistās company, alleging adverse side effects.
California officials should have obtained federal approval before they cut reimbursement rates for dental hygienists who serve frail Californians living in nursing homes and board-and-care facilities, a judge has ruled.
In this episode of KHNās āWhat the Health?ā Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Sarah Kliff of Vox discuss the latest lawsuit challenging the constitutionality of the Affordable Care Act. They also explore how your health care system increasingly depends on the state you live in. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
Although the potentially fatal disease isĀ common among the incarcerated, treatment with the latest hepatitis drugs isn't.
The Seattle jurist finds that Olympus Corp. failed to properly disclose evidence that it knew of concerns about cleaning problems with its redesigned medical scopes years before they hit the market and were linked to dozens of deaths. The company maintains the devices were not defective and intends to appeal.
In a low-tech snafu, information about HIV treatment was visible through the cellophane window on envelopes sent to about 12,000 consumers.
Complaints are rising in California and other states about improper evictions and discharges. Advocates say some patients end up in cheap hotels, homeless or back in the hospital.
"'Fingers crossed' that I havenāt authorized something the FTC will hunt me down for,ā a staffer wrote after destroying the documents. Sutter, a huge Northern California Health system with 24 hospitals, said it destroyed them by mistake.
Complaints are rising against for-profit insurance companies that manage Medicaid for about 600,000 Iowans. The privatization of Medicaid is a national trend affecting more than half of the 74 million Americans who get their health care through the state-federal program.
Advocates say Californiaās Medicaid program is violating its own rules by overturning decisions that would allow seriously ill patients to stay out of managed care and keep their doctors.
Some drug courts offer participants a full range of evidence-based treatment, including medication-assisted treatment. Others don't allow addiction medications at all. And some permit just one: Vivitrol.
Court allows state attorneys general to join a pending legal challenge to keep billions in subsidies flowing to consumers and insurers, despite the Trump administrationās resistance.
The Affordable Care Act has repeatedly faced opposition in Congress and the courts, but it has continued to survive.
The Affordable Care Act has repeatedly faced opposition in Congress and the courts, but it has continued to survive.
Ā© 2026 KFF